Neuroscience
Antipsychotic
100%
positron emission tomographic scan
82%
Fluorine-18
77%
Positron Emission Tomography
74%
Bipolar Disorder
49%
DOPA
44%
Striatum
38%
Anterior Cingulate Cortex
35%
Dopaminergic
33%
Glutamic Acid
33%
Hippocampus
30%
Antidepressant
29%
Molecular Imaging
29%
Negative Syndrome
27%
In Vivo
24%
Positive Syndrome
22%
Arterial Spin Labeling
22%
Magnetic Resonance Imaging
19%
Nuclear Magnetic Resonance Spectroscopy
19%
Frontal Lobe
19%
Randomized Controlled Trial
18%
Histamine H3 Receptor
16%
Serotonin
16%
Gray Matter
16%
Temporal Lobe
16%
Hamilton Rating Scale for Depression
16%
Apomorphine
16%
Parkinson's Disease
16%
Meta-Analysis
13%
Occipital Lobe
11%
Major Depressive Disorder
10%
Dorsolateral Prefrontal Cortex
8%
Parietal Lobe
8%
Thalamus
8%
Amygdala
8%
Placebo
7%
Neurotransmitter
5%
Functional Connectivity
5%
Resting-State Functional Connectivity
5%
Individual Differences
5%
Default Mode Network
5%
Brain Disease
5%
Medicine and Dentistry
Antipsychotic
53%
Positron Emission Tomography
49%
Systematic Review
41%
Fluorine-18
38%
Antidepressant
29%
Maintenance Therapy
24%
Biological Marker
23%
Meta-Analysis
20%
Dopamine Metabolism
17%
Effect Size
17%
Early Intervention
16%
Anterior Cingulate
16%
Proton Nuclear Magnetic Resonance
16%
Cingulate Cortex
16%
Clinical Significance
16%
Side Effect
16%
Hamilton Rating Scale for Depression
16%
Electronic Health Record
16%
Clinical Research
16%
Cohort Effect
16%
Muscarinic Agonist
16%
Glutamic Acid
16%
Bipolar Disorder
16%
Targeted Therapy
16%
Care Pathway
16%
Diseases
16%
Allosteric Modulator
16%
Affective Psychosis
16%
Polyethylene Terephthalate
16%
Radiomics
16%
Striatum
16%
Magnetic Resonance Imaging
16%
Clozapine
11%
Pharmacological Treatment
11%
Functional Connectivity
11%
Standardized Uptake Value
9%
Clinical Trial
8%
Major Depressive Episode
8%
Volunteer
8%
Cohort Analysis
8%
Mental Health Service
8%
Emergency Department
8%
Radioactive Tracer
6%
Reproducibility
6%
Prepulse Inhibition
5%
Resting-State Magnetic Resonance Imaging
5%
Muscarinic Acetylcholine Receptor
5%
Independent Reviewer
5%
Population Model
5%
Social Interaction
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
36%
Bipolar Disorder
33%
Fluorine 18
33%
Polyethylene Terephthalate
33%
Biological Marker
20%
Dopamine Receptor Stimulating Agent
19%
Clozapine
19%
Positive Allosteric Modulator
16%
Diseases
16%
Cohort Study
16%
Muscarinic Agent
16%
Randomized Controlled Trial
16%
DOPA
16%
Affective Psychosis
16%
Glutamic Acid
16%
Serotonin
16%
Apomorphine
16%
Placebo
7%
Pathophysiology
6%
Normal Human
5%
Muscarinic Receptor
5%
Clinical Trial
5%
Xanomeline
5%
Drug Development
5%
